| Dec 31,
2019 | Dec 31,
2020 | Dec 31,
2021 | Dec 31,
2022 | Dec 31,
2023 | Dec 31,
2024 |
|---|
| Net profit (loss) and total comprehensive profit (loss) | -10 | -5 | -6 | -13 | -4 | 3 |
|---|
| Depreciation and amortization | 2 | 1 | 1 | 1 | 0 | 1 |
|---|
| Depreciation of leased systems | - | 1 | 1 | 1 | 1 | 1 |
|---|
| Impairment and disposal of inventory and system components | - | - | - | - | 1 | 2 |
|---|
| Finance expenses (income), net | - | - | - | - | - | 2 |
|---|
| Cost of share-based payment | 1 | 1 | 2 | 1 | 0 | 1 |
|---|
| Income taxes | 0 | 0 | 0 | 0 | 0 | 1 |
|---|
| Total adjustments to reconcile loss | 6 | 4 | 6 | 4 | 2 | 3 |
|---|
| Increase in inventory | - | - | - | -4 | -1 | -1 |
|---|
| Decrease (increase) in trade receivables | -3 | -0 | -1 | 1 | 1 | -1 |
|---|
| Decrease (increase) in other current assets | - | - | - | - | -0 | 2 |
|---|
| Increase (decrease) in trade payables | 0 | -1 | 0 | - | -0 | 2 |
|---|
| Increase in other accounts payable | -0 | 1 | 1 | 0 | 0 | 0 |
|---|
| Increase in deferred revenues | - | - | 2 | 1 | 2 | 0 |
|---|
| Total changes in asset and liability | - | 0 | 1 | -1 | 2 | 2 |
|---|
| Interest paid | 0 | 0 | 0 | 0 | 0 | 0 |
|---|
| Interest received | 0 | 0 | 0 | 1 | 2 | 3 |
|---|
| Income taxes paid | 1 | 0 | 0 | 0 | 0 | 1 |
|---|
| Total cash received during the year | - | -0 | -0 | 1 | 1 | 2 |
|---|
| Net cash provided by (used in) operating activities | -7 | -1 | 1 | -10 | 1 | 10 |
|---|
| Proceeds from disposal (purchase) of property and equipment and system components, net | - | - | - | - | -2 | -4 |
|---|
| Proceeds from lease assets | - | - | - | - | - | 0 |
|---|
| Proceeds from short-term bank deposits | - | - | - | - | - | 35 |
|---|
| Investment in long-term deposits, net | - | - | 0 | -0 | -0 | -1 |
|---|
| Net cash provided by (used in) investing activities | -2 | -2 | -42 | 42 | -37 | 30 |
|---|
| Repayment of liability in respect of research and development grants | - | - | - | - | - | 1 |
|---|
| Repayment of lease liabilities | - | - | - | - | - | 0 |
|---|
| Exercise of share options | - | - | - | - | - | 0 |
|---|
| Issuance of warrants liability | - | - | - | - | - | 3 |
|---|
| Proceeds from issuance of shares, net | - | - | - | - | - | 16 |
|---|
| Net cash provided by (used in) financing activities | 22 | -1 | 42 | -2 | -1 | 18 |
|---|
| Exchange rate differences on balance of cash and cash equivalents | -0 | 0 | -0 | -0 | 0 | -0 |
|---|
| Increase (decrease) in cash and cash equivalents | 13 | -5 | -0 | 31 | -37 | 59 |
|---|
| Right-of-use asset recognized with corresponding lease liability | - | - | - | - | - | 6 |
|---|